Befotertinib Mesylate | m-entrepreneurship.com

Product Name :
Befotertinib Mesylate

Search keywords :
Befotertinib

drugId :
null

Target Vo:
EGFR T790M

Target Vo Short Name :
EGFR T790M

Moa_Name:
EGFR T790M inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
2023

Origin Company_Name :
Inventisbio Co Ltd

Active Company_Name :
Betta Pharmaceuticals Co Ltd

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Gantenerumab Purity & Documentation
Phospho-STAT1 (Ser727) Rabbit mAb Epigenetic Reader Domain
RSK1 p90 Antibody (YA088): RSK1 p90 Antibody (YA088) is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to RSK1 p90. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts